ms.spr.ly/6012tiOtQ Doctors report that GLP-1 medications, originally approved for obesity and diabetes, are increasingly being used to help women with Polycystic Ovary Syndrome (PCOS) a hormonal disorder often tied to weight gain, insulin resistance, and fertility issues
ATTAIN-1 was a 72-week, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of orforglipron (6 mg, 12 mg, and 36 mg) as monotherapy vs
the goal is to treat the root of your health issue
Lawsuits argue that drug manufacturers failed to properly warn diabetes patients that these medications may increase the risk of vision problems
It also comes with potential side effects, albeit rare ones, including breathing issues (with spray products) and skin inflammation in some people
P2 4, P2X purinoreceptor 4